| Gene symbol | BIRC5 | Synonyms | API4, EPR-1 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | baculoviral IAP repeat containing 5 | ||||
| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC1591 |
| Trial ID | NCT02693236 |
| Disease | Esophageal Cancer |
| Altered gene | MUC1|BIRC5 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | mRNA vaccine |
| Treatment | DC Vaccine|CIK cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Clinical Research of Genetically Modified Dendritic Cells in Combination With Cytokine-induced Killer Cell Treatment in Middle and Advanced Esophagus Cancer Patients |
| Year | 2014 |
| Country | China |
| Company sponsor | Affiliated Hospital to Academy of Military Medical Sciences |
| Other ID(s) | 307-CTC-DC/CIK-EC |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||